Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
Condition(s):Postpartum Hemorrhage; Uterine AtonyLast Updated:January 11, 2012Withdrawn
Hide Studies Not Open or Pending
Condition(s):Postpartum Hemorrhage; Uterine AtonyLast Updated:January 11, 2012Withdrawn
Condition(s):Cesarean Section During LaborLast Updated:January 31, 2017Unknown status
Condition(s):Blood Loss Anemia; Uterine Atony With HemorrhageLast Updated:February 21, 2019Withdrawn
Condition(s):Postpartum HemorrhageLast Updated:March 17, 2014Completed
Condition(s):Hemorrhage of Cesarean Section and/or Perineal Wound; Postpartum Hemorrhage; Uterine AtonyLast Updated:September 5, 2016Completed
Condition(s):Induction of LaborLast Updated:June 12, 2017Completed
Condition(s):Postpartum HemorrhageLast Updated:November 11, 2010Completed
Condition(s):Primary Postpartum HaemorrhageLast Updated:April 30, 2015Unknown status
Condition(s):Postpartum Hemorrhage; Cesarean Section Complications; Uterine AtonyLast Updated:January 5, 2024Not yet recruiting
Condition(s):Uterine Inertia; DystociaLast Updated:November 20, 2015Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.